{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T01:27:24Z","timestamp":1791336444417,"version":"4.3.1"},"reference-count":31,"publisher":"Japanese Pharmacological Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Pharmacol Sci"],"published-print":{"date-parts":[[2009]]},"DOI":"10.1254\/jphs.08229fp","type":"journal-article","created":{"date-parts":[[2009,3,23]],"date-time":"2009-03-23T05:56:36Z","timestamp":1237787796000},"page":"449-455","source":"Crossref","is-referenced-by-count":20,"title":["Characteristic Effects of Anti-dementia Drugs on Rat Sleep Patterns"],"prefix":"10.1254","volume":"109","author":[{"given":"Takayuki","family":"Ishida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiaki","family":"Kamei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"332","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Bliwise DL. Sleep disorders in Alzheimer’s disease and other dementias. Clin Cornerstone. 2004;6:16–28.","DOI":"10.1016\/S1098-3597(04)90014-2"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Moran M, Lynch CA, Walsh C, Coen R, Coakley D, Lawlor BA. Sleep disturbance in mild to moderate Alzheimer’s disease. Sleep Med. 2005;6:347–352.","DOI":"10.1016\/j.sleep.2004.12.005"},{"key":"3","unstructured":"3 Zivin M, Pregelj P. Prolonged treatment with donepezil increases acetylcholinesterase expression in the central nervous system. Psychiatr Danub. 2008;20:168–173."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Lopes C, Pereira EF, Wu HQ, Purushottamachar P, Njar V, Schwarcz R, et al. Competitive antagonism between the nicotinic allosteric potentiating ligand galantamine and kynurenic acid at alpha7* nicotinic receptors. J Pharmacol Exp Ther. 2007;322:48–58.","DOI":"10.1124\/jpet.107.123109"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Wang D, Noda Y, Zhou Y, Mouri A, Mizoguchi H, Nitta A, et al. The allosteric potentiation of nicotinic acetylcholine receptors by galantamine ameliorates the cognitive dysfunction in beta amyloid25–35 i.c.v.-injected mice: involvement of dopaminergic systems. Neuropsychopharmacology. 2007;32:1261–1271.","DOI":"10.1038\/sj.npp.1301256"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Lerner AJ, McClendon MJ, Sami SA, Ogrocki PK, Adams KB, Smyth KA. Factors affecting usage patterns of memantine in Alzheimer disease. Alzheimer Dis Assoc Disord. 2008,22:137–143.","DOI":"10.1097\/WAD.0b013e31815ccd68"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(93)90464-X"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Ancoli-Israel S, Amatniek J, Ascher S, Sadik K, Ramaswamy K. Effects of galantamine versus donepezil on sleep in patients with mild to moderate Alzheimer disease and their caregivers: a double-blind, head-to-head, randomized pilot study. Alzheimer Dis Assoc Disord. 2005;19:240–245.","DOI":"10.1097\/01.wad.0000189052.48688.36"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Moraes WS, Poares DR, Guileminault C, Ramos LR, Bertolucci PH, Tufik SD. The effect of donepezil on sleep and REM sleep sleep EEG in patients with alzheimer disease: A double-blind placebo-controlled study. Sleep. 2006;29:199–205.","DOI":"10.1093\/sleep\/29.2.199"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Wisor JP, Edgar DM, Yesavage J, Ryan HS, McCormick CM, Lapustea N, et al. Sleep and circadian abnormalities in a transgenic mouse model of Alzheimer’s disease: a role for cholinergic transmission. Neuroscience. 2005;131:375–385.","DOI":"10.1016\/j.neuroscience.2004.11.018"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Blesa R. Galantmaine: therapeutic effects beyond cognition. Dement Geriatr Cogn Disord. 2000;Suppl 1:28–34.","DOI":"10.1159\/000051229"},{"key":"12","unstructured":"12 Paxinos G, Watson C. The rat brain in stereotaxic coordinates 6th ed. San Doago: Academic Press; 2007."},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.181330998"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Shinomiya K, Shigemoto Y, Omichi J, Utsu Y, Mio M, Kamei C. Effects of three hypnotics on the sleep-wakefulness cycle in sleep-disturbed rats. Psychopharmacology (Berl). 2004;173:203–209.","DOI":"10.1007\/s00213-003-1727-0"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Shinomiya K, Inoue T, Utsu Y, Tokunaga S, Masuoka T, Ohmori A, et al. Effects of kava-kava extract on the sleep-wake cycle in sleep-disturbed rats. Psychopharmacology (Berl). 2005;180:564–569.","DOI":"10.1007\/s00213-005-2196-4"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Hirase M, Ishida T, Kamei C. Rebound insomnia induced by abrupt withdrawal of hypnotics in sleep-disturbed rats. Eur J Pharmacol. 2008;597:46–50.","DOI":"10.1016\/j.ejphar.2008.08.024"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1254\/jphs.08059FP"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2005.02.036"},{"key":"19","doi-asserted-by":"publisher","DOI":"10.1007\/BF02253584"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Zoladz PR, Campbell AM, Park CR, Schaefer D, Danysz W, Diamond DM. Enhancement of long-term spatial memory in adult rats by the noncompetitive NMDA receptor antagonists, memantine and neramexane. Pharmacol Biochem Behav. 2006;85:298–306.","DOI":"10.1016\/j.pbb.2006.08.011"},{"key":"21","doi-asserted-by":"publisher","DOI":"10.1254\/jphs.FP0061173"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Schredl M, Weber B, Braus D, Gattaz WF, Berger M, Riemann D, et al. The effect of rivastigmine on sleep in elderly healthy subjects. Exp Gerontol. 2000;35:243–249.","DOI":"10.1016\/S0531-5565(00)00077-2"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Hedner J, Kraiczi J, Peker Y, Murphy P. Reduction of sleep-disordered breathing after physostigmine. Am J Respir Crit Care Med. 2003;168:1246–1251.","DOI":"10.1164\/rccm.200211-1344OC"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Markowitz JS, Gutterman EM, Lilienfeld S, Papadopoulos G. Sleep-related outcomes in persons with mild to moderate Alzheimer disease in a placebo-controlled trial of galantamine. Sleep. 2003;26:602–606.","DOI":"10.1093\/sleep\/26.5.602"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Geerts H, Guillaumat PO, Grantham C, Bode W, Anciaux K, Sachak S. Brain levels and acetylcholinesterase inhibition with galantamine and donepezil in rats, mice, and rabbits. Brain Res. 2005;1033:186–193.","DOI":"10.1016\/j.brainres.2004.11.042"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Ogura H, Kosasa T, Kuriya Y, Yamanishi Y. Comparison of inhibitory activities of donepezil and other cholinesterase inhibitors on acetylcholinesterase and butyrylcholinesterase in vitro. Method Find Exp Clin Pharmacol. 2000;22:609–613.","DOI":"10.1358\/mf.2000.22.8.701373"},{"key":"27","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(94)00379-W"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Stone WS, Walker DL, Gold PE. Sleep deficits in rats after NMDA receptor blockade. Physiol Behav. 1992;52:609–612.","DOI":"10.1016\/0031-9384(92)90355-6"},{"key":"29","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(94)90023-X"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Monti JM, Monti D. The involvement of dopamine in the modulation of sleep and waking. Sleep Med Rev. 2007;11:113–133.","DOI":"10.1016\/j.smrv.2006.08.003"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Hanania T, Zahniser NR. Locomotor activity induced by noncompetitive NMDA receptor antagonists versus dopamine transporter inhibitors: opposite strain differences in inbred long-sleep and short-sleep mice. Alcohol Clin Exp Res. 2002;26:431–440.","DOI":"10.1111\/j.1530-0277.2002.tb02558.x"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T15:05:31Z","timestamp":1621436731000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/jphs\/109\/3\/109_08229FP\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1254\/jphs.08229fp","relation":{},"ISSN":["1347-8613","1347-8648"],"issn-type":[{"value":"1347-8613","type":"print"},{"value":"1347-8648","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009]]}}}